Publications by authors named "Deeksha Vishwamitra"

13Publications

Type I insulin-like growth factor receptor signaling in hematological malignancies.

Oncotarget 2017 Jan;8(1):1814-1844

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
January 2017

IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

J Natl Cancer Inst 2016 12 30;108(12). Epub 2016 Aug 30.

Departments of Sarcoma Medical Oncology (SELC, BAM, VR, RSB, RR, JAL), Hematopathology (DV, HMA), Bioinformatics and Computational Biology (YW, JW), Investigational Cancer Therapeutics (AN, VS), Pediatrics-Patient Care (NCD), Experimental Therapeutics (IF, SS, WP), and Pathology (AJL), The University of Texas MD Anderson Cancer Center, Houston, TX; Departments of Radiology (EMR) and Molecular & Human Genetics (RLM), Baylor College of Medicine, Houston, TX; Department of Pediatric-Oncology, Texas Children's Hospital. Houston, TX (ASB); Departments of Chemical and Biomolecular Engineering and Bioengineering, Rice University, Houston, TX (AGM)

View Article and Find Full Text PDF
December 2016

SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein.

Neoplasia 2015 Sep;17(9):742-754

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; The University of Texas Graduate School of Biomedical Sciences, Houston, TX. Electronic address:

View Article and Find Full Text PDF
September 2015

The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.

Mol Cancer 2015 Feb 25;14:53. Epub 2015 Feb 25.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, USA.

View Article and Find Full Text PDF
February 2015

The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.

Oncotarget 2014 Jul;5(14):5750-63

Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; The University of Texas Graduate School of Biomedical Sciences, Houston, TX.

View Article and Find Full Text PDF
July 2014

NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism.

J Pathol 2013 May 14;230(1):82-94. Epub 2013 Mar 14.

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
May 2013

MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.

Am J Pathol 2012 May 10;180(5):1772-80. Epub 2012 Mar 10.

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
May 2012

Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma.

Haematologica 2011 Jun 17;96(6):871-80. Epub 2011 Feb 17.

Department of Hematopathology, Unit 72, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
June 2011